期刊文献+

HPV感染与宫颈鳞癌临床病理因素的相关性分析 被引量:9

Analysis of correlation between HPV infection and clinicopathological factors of cervical squamous cell carcinoma
下载PDF
导出
摘要 目的:分析HPV感染与宫颈鳞癌临床病理因素的相关性。方法:回顾分析中南大学湘雅三医院因宫颈鳞癌行广泛子宫全切及盆腔淋巴结清扫的184例患者的HPV感染情况、TCT结果、肿瘤分期(IA^IIB)、分化程度、肿瘤直径、淋巴结转移情况、间质浸润深度等临床资料,探讨宫颈鳞癌患者HPV感染情况及其与临床病理因素的相关性。结果:184例宫颈鳞癌患者的HPV阳性率为92.9%,其中单一感染占63.6%,多重感染占29.3%,单一感染中前四位HPV感染类型依次为HPV16、18、58、45,多重感染中前四位HPV感染类型依次为HPV16、33、52、18。HPV单一感染的宫颈鳞癌患者较多重感染者的FIGO分期更晚且更易发展为巨块型宫颈癌;HPV感染类型与宫颈鳞癌的临床病理因素之间无相关性。结论:HPV感染模式可影响宫颈鳞癌的临床表现及复发相关因素。 Objective: To analyze the correlation between HPV infection and clinico- pathological factors of cervical squamous cell carcinoma. Methods: Clinical data of 184 cervical squamous cell carcinoma patients who had undergone radical hysterectomy and bilateral pelvic lymphadeneetomy were retrospectively analyzed, including HPV, TCT results, tumor staging ( IAIIB) , degree of differentiation, lymph node metastasis, tumor diameter, depth of stromal inva- sion. Results: HPV of any type was detected in 92.9% of all cases in which the single infection accounted for 63.6%, multiple infection accounted for 29.3% , among single infection the first four types were : 16,18,58,45 ; among multiple 52,18. Statistic analysis indicates that: patients infection the first four types were:HPV16,33, with single hr-HPV infection in early cervical squamous cell carcinoma are more likely to develop bulky cervical cancer (tumor diameter 1〉 4cm), and later FIGO stage;there is no correlation between HPV types and clinical pathological factors of squamous cell carcinoma of cervix. Conclusion:Pattern of HPV infection effects the clinical manifestations and recurrence factors of cervical squamous cell carcinoma.
出处 《现代妇产科进展》 CSCD 北大核心 2015年第7期521-523,共3页 Progress in Obstetrics and Gynecology
基金 中南大学中央高校基本科研业务费专项资金资助(No:2014zzts377) 湖南省科技厅计划项目(No:2013FJ4092) 国家自然科学基金(No:81402270) 湖南省科技厅重点项目(No:2012FJ2014) 湖南省卫生厅一般项目(No:B2015-042)
关键词 人乳头瘤病毒 宫颈癌 高危因素 HPV Cervical cancer Risk factors
  • 相关文献

参考文献9

  • 1Siegel R,Ward E,Brawley O,et al. Cancer statistics ,2011 :the impact of eliminating socioeconomic and racial disparities on premature cancer deaths [ J ]. CA Cancer J Clin,2011,61 (4) : 212-256.
  • 2Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide bur- den of cancer in 2008 : GLOBOCAN 2008 [ J ]. Int J Cancer, 2010,127(12) :2895-2917.
  • 3Walboomers JM,Jacobs MV ,Manos MM,et al. Human papil- lomavirus is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999,189 ( 1 ) : 12-19.
  • 4Fuller AF, Elliott N, Kosloff C, et al. Determinants of in- creased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix [ J ]. Gynecol Oncol, 1989,33 ( 1 ) :34-39.
  • 5Delgado G, Bundy BN, Fowler WC Jr, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix:a gynecologic oncology group study [ J ]. Gynecol Oncol, 1989,35 (3) :314-320.
  • 6Smith JS,Lindsay L,Hoots B,et al. HPV type distribution in invasive cervical cancer and high-garde cervical neoplasia:an update of meta-analyses and identification of globle data gaps [J], Br J Cancer,2007,121 (3) :621-632.
  • 7Graflund M, Sorbe B, Sigurdardettir S, et al. HPV-DNA, vas- cular space invasion,and their impact on the clinical outcome in early-stage cervical carcinomas[J], Int J Gynecol Cancer, 2004,14(5) :896-902.
  • 8Monk BJ, Cha DS, Walker JL, et al. Extent of disease as anindication for pelvic radiation following radical hysterecto- my and bilateral pelvic lymph node dissection in the treat- ment of stage IB and I/A cervical carcinoma[J]. Gynecol Onco1,1994,54( 1 ) :4-9.
  • 9Michimata R, Watari H, Tomaru U, et al. Human papilloma- virus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfec- tion with human papillomavirus 34 [ J ]. Pathobiol, 2013,80 (5) :259-264.

同被引文献90

引证文献9

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部